Arginine methylation of hnRNP A2 does not directly govern its subcellular localization. 2013

Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.

The hnRNP A/B paralogs A1, A2/B1 and A3 are key components of the nuclear 40S hnRNP core particles. Despite a high degree of sequence similarity, increasing evidence suggests they perform additional, functionally distinct roles in RNA metabolism. Here we identify and study the functional consequences of differential post-translational modification of hnRNPs A1, A2 and A3. We show that while arginine residues in the RGG box domain of hnRNP A1 and A3 are almost exhaustively, asymmetrically dimethylated, hnRNP A2 is dimethylated at only a single residue (Arg-254) and this modification is conserved across cell types. It has been suggested that arginine methylation regulates the nucleocytoplasmic distribution of hnRNP A/B proteins. However, we show that transfected cells expressing an A2(R254A) point mutant exhibit no difference in subcellular localization. Similarly, immunostaining and mass spectrometry of endogenous hnRNP A2 in transformed cells reveals a naturally-occurring pool of unmethylated protein but an exclusively nuclear pattern of localization. Our results suggest an alternative role for post-translational arginine methylation of hnRNPs and offer further evidence that the hnRNP A/B paralogs are not functionally redundant.

UI MeSH Term Description Entries
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations
D034481 Heterogeneous-Nuclear Ribonucleoprotein Group A-B A class of closely related heterogeneous-nuclear ribonucleoproteins of approximately 34-40 kDa in size. Although they are generally found in the nucleoplasm, they also shuttle between the nucleus and the cytoplasm. Members of this class have been found to have a role in mRNA transport, telomere biogenesis and RNA SPLICING. hnRNP A-B Proteins,A-B Family hnRNP Proteins,Heterogeneous Nuclear Ribonucleoprotein A2-B1,Type A-B hnRNP Proteins,hnRNP A2-B1,A B Family hnRNP Proteins,Heterogeneous Nuclear Ribonucleoprotein A2 B1,Heterogeneous Nuclear Ribonucleoprotein Group A B,Type A B hnRNP Proteins,hnRNP A B Proteins

Related Publications

Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
May 2000, Experimental cell research,
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
May 2004, The Journal of biological chemistry,
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
May 2014, FEBS letters,
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
January 2003, Rheumatology (Oxford, England),
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
July 2010, BMC cancer,
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
May 2008, FEBS letters,
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
March 1998, Genes & development,
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
July 2010, Traffic (Copenhagen, Denmark),
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
March 1991, Biochimica et biophysica acta,
Lexie R Friend, and Michael J Landsberg, and Amanda S Nouwens, and Ying Wei, and Joseph A Rothnagel, and Ross Smith
June 2021, Nature communications,
Copied contents to your clipboard!